These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 222512

  • 1. Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies.
    Lopes-Virella M, Virella G, Debeukelaer M, Owens CJ, Colwell JA.
    Clin Chim Acta; 1979 May 16; 94(1):73-81. PubMed ID: 222512
    [Abstract] [Full Text] [Related]

  • 2. Urinary high density lipoprotein--a possible marker for glomerular proteinuria.
    Gomo Z.
    Cent Afr J Med; 1991 Jul 16; 37(7):211-6. PubMed ID: 1811905
    [Abstract] [Full Text] [Related]

  • 3. High-density lipoprotein apolipoproteins in urine: I. Characterization in normal subjects and in patients with proteinuria.
    Gomo ZA, Henderson LO, Myrick JE.
    Clin Chem; 1988 Sep 16; 34(9):1775-80. PubMed ID: 3138041
    [Abstract] [Full Text] [Related]

  • 4. Urinary tumor necrosis factor levels in primary glomerulopathies.
    Ozen S, Saatci U, Tinaztepe K, Bakkaloglu A, Barut A.
    Nephron; 1994 Sep 16; 66(3):291-4. PubMed ID: 8190181
    [Abstract] [Full Text] [Related]

  • 5. High-density lipoprotein apolipoproteins in urine: II. Enzyme-linked immunoassay of apolipoprotein A-I.
    Gomo ZA, Henderson LO.
    Clin Chem; 1988 Sep 16; 34(9):1781-6. PubMed ID: 3138042
    [Abstract] [Full Text] [Related]

  • 6. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR, Havel RJ, Kane JP.
    Am J Epidemiol; 1982 Aug 16; 116(2):302-13. PubMed ID: 6810694
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease.
    Hotta O, Sugai H, Kitamura H, Yusa N, Taguma Y.
    Kidney Int; 2004 Dec 16; 66(6):2374-81. PubMed ID: 15569329
    [Abstract] [Full Text] [Related]

  • 8. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B, Tomura H, Kuwabara A, Kimura T, Miura S, Noda K, Okajima F, Saku K.
    Atherosclerosis; 2005 Jan 16; 178(1):199-205. PubMed ID: 15585219
    [Abstract] [Full Text] [Related]

  • 9. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E, Rosseneu M, Bury J, Stul M, Lamberigts G, De Moor P.
    J Clin Endocrinol Metab; 1985 Nov 16; 61(5):882-9. PubMed ID: 3930554
    [Abstract] [Full Text] [Related]

  • 10. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH.
    Br J Sports Med; 2004 Jun 16; 38(3):253-9. PubMed ID: 15155420
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein derangement during steroid treatment in minimal-change nephrotic syndrome.
    Tsukamoto Y, Kokubo T, Horii A, Moriya R, Kobayashi Y.
    Nephron; 1996 Jun 16; 73(4):606-12. PubMed ID: 8856259
    [Abstract] [Full Text] [Related]

  • 12. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE.
    J Clin Endocrinol Metab; 2001 Jul 16; 86(7):3134-42. PubMed ID: 11443178
    [Abstract] [Full Text] [Related]

  • 13. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns.
    Averna MR, Barbagallo CM, Di Paola G, Labisi M, Pinna G, Marino G, Dimita U, Notarbartolo A.
    Biol Neonate; 1991 Jul 16; 60(3-4):187-92. PubMed ID: 1797121
    [Abstract] [Full Text] [Related]

  • 14. Serum and urinary high density lipoproteins in glomerular disease with proteinuria.
    Short CD, Durrington PN, Mallick NP, Hunt LP, Tetlow L, Ishola M.
    Kidney Int; 1986 Jun 16; 29(6):1224-8. PubMed ID: 3091902
    [Abstract] [Full Text] [Related]

  • 15. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ, van Gent CM, Buytenhek R, Buis B.
    J Lab Clin Med; 1987 Jan 16; 109(1):19-26. PubMed ID: 3098880
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study of urine immunoelectrophoresis and 4 indexes of glomerular selectivity in chronic glomerulopathies].
    Cahen R, François B, Sabot JF, Bernard P, Picq JP, Adeleine P.
    Pathol Biol (Paris); 1985 Jan 16; 33(1):23-6. PubMed ID: 3975073
    [Abstract] [Full Text] [Related]

  • 17. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Jan 16; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 18. [Behavior of total lipids, cholesterol, lipoproteins and apolipoprotein A in the blood of subjects with acute hepatitis and chronic hepatopathy].
    Vergani C, Trovato G, Pietrogrande M, Crocchiolo P, Dioguardi N.
    Minerva Med; 1978 Jun 23; 69(31):2081-94. PubMed ID: 208025
    [Abstract] [Full Text] [Related]

  • 19. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A, Sobbrio GA, D'Arrigo F, Barillari M, Curasì MP, Egitto M, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Jun 23; 21(3):143-6. PubMed ID: 2149913
    [Abstract] [Full Text] [Related]

  • 20. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment.
    Muls E, Blaton V, Rosseneu M, Lesaffre E, Lamberigts G, De Moor P.
    J Clin Endocrinol Metab; 1982 Sep 23; 55(3):459-64. PubMed ID: 6808006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.